Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion type Assertion NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_head.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion description "[Our results indicated that Src kinase is pathogenically activated in lymphomagenesis induced by FGFR1 fusion genes, implying that Src kinase inhibitors may offer a useful option to treatment of FGFR1-associated myeloproliferative/lymphoma disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion evidence source_evidence_literature NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion SIO_000772 21937681 NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion wasDerivedFrom befree-20150227 NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.
- NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_assertion wasGeneratedBy ECO_0000203 NP400340.RAln6eyNpWx1ja4OjI3X0KAEchF0QEAWuKZiaSJmpMJ0g130_provenance.